Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.;Institute of Materia Medica, Chinese Academy of Medical Sciences
发明人:
ZHU, Haibo,WANG, Jing
申请号：
EP17765790
公开号：
EP3431091A4
申请日:
2017.03.10
申请国别(地区):
EP
年份:
2019
代理人:
摘要：
Provided are uses of an adenosine derivative, shown in formula (I), in preparing pharmaceuticals for the prevention or/and treatment of hyperlipidemia-associated monocytosis, and for the prevention or/and treatment of atherosclerosis. The prevention or/and treatment of atherosclerosis refers to the prevention or/and treatment of atherosclerosis-associated inflammatory monocytosis.
